{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:57:39Z","timestamp":1793476659484,"version":"4.5.0"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.38444","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T16:02:00Z","timestamp":1639411320000},"page":"e2138444","source":"Crossref","is-referenced-by-count":2,"title":["Treatment and Survival Outcomes Associated With Platinum Plus Low-Dose, Long-term Fluorouracil for Metastatic Nasopharyngeal Carcinoma"],"prefix":"10.1001","volume":"4","author":[{"given":"Shuo-Han","family":"Zheng","sequence":"first","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Ran","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Bo","family":"Wang","sequence":"additional","affiliation":[{"name":"Peking University Clinical Research Institute, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Hong","family":"Wei","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-Nan","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"Department of Head and Neck Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Lu","family":"Huang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Rong","family":"Ding","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Lan","family":"Tao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology and Endocrinology, The PLA 74th Group Army Hospital, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Glorieux","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Huang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"Center for Cancer Metabolism and Intervention Research, Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Feng","family":"Wu","sequence":"additional","affiliation":[{"name":"Peking University Clinical Research Institute, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Fei","family":"Xia","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China"},{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,12,13]]},"reference":[{"issue":"3","key":"zoi211085r1","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/0360-3016(95)02126-V","article-title":"Nasopharynx carcinoma: choice of treatment.","volume":"33","author":"al-Sarraf","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"zoi211085r2","first-page":"129","article-title":"Natural development of nasopharyngeal carcinoma and clinical types of late stage cases.","volume":"1","author":"Xie","year":"1963","journal-title":"Tientsin Med J"},{"issue":"4","key":"zoi211085r3","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.ijrobp.2006.06.028","article-title":"Radiotherapy-related typing in 842 patients in canton with nasopharyngeal carcinoma.","volume":"66","author":"Li","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"zoi211085r4","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","article-title":"Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma.","volume":"381","author":"Zhang","year":"2019","journal-title":"N Engl J Med"},{"issue":"14","key":"zoi211085r5","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1200\/JCO.2017.77.0388","article-title":"Antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: an international, multicenter study of the Mayo Clinic Phase 2 Consortium (NCI-9742).","volume":"36","author":"Ma","year":"2018","journal-title":"J Clin Oncol"},{"issue":"10","key":"zoi211085r6","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/S1470-2045(18)30495-9","article-title":"Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials.","volume":"19","author":"Fang","year":"2018","journal-title":"Lancet Oncol"},{"issue":"36","key":"zoi211085r7","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1200\/JCO.2017.73.3675","article-title":"Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1-positive nasopharyngeal carcinoma: results of the KEYNOTE-028 Study.","volume":"35","author":"Hsu","year":"2017","journal-title":"J Clin Oncol"},{"issue":"15","key":"zoi211085r8","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1200\/JCO.2005.02.147","article-title":"Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.","volume":"23","author":"Chan","year":"2005","journal-title":"J Clin Oncol"},{"key":"zoi211085r9","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.1016\/j.ijrobp.2012.07.391","article-title":"A phase II trial of proton radiation therapy with chemotherapy for nasopharyngeal carcinoma.","volume":"84","author":"Chan","year":"2012","journal-title":"Int J Radiat Oncol"},{"issue":"3","key":"zoi211085r10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.radonc.2012.08.013","article-title":"A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma.","volume":"104","author":"Peng","year":"2012","journal-title":"Radiother Oncol"},{"issue":"9476","key":"zoi211085r11","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/S0140-6736(05)66698-6","article-title":"Nasopharyngeal carcinoma.","volume":"365","author":"Wei","year":"2005","journal-title":"Lancet"},{"issue":"10054","key":"zoi211085r12","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/S0140-6736(16)31388-5","article-title":"Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.","volume":"388","author":"Zhang","year":"2016","journal-title":"Lancet"},{"issue":"11","key":"zoi211085r13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.21037\/atm","article-title":"The efficacy of first-line chemotherapy in recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis.","volume":"6","author":"Ma","year":"2018","journal-title":"Ann Transl Med"},{"issue":"11","key":"zoi211085r14","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/S1470-2045(16)30410-7","article-title":"Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial.","volume":"17","author":"Sun","year":"2016","journal-title":"Lancet Oncol"},{"issue":"53","key":"zoi211085r15","doi-asserted-by":"publisher","first-page":"91150","DOI":"10.18632\/oncotarget.v8i53","article-title":"Addition of 5-fluorouracil to first-line induction chemotherapy with docetaxel and cisplatin before concurrent chemoradiotherapy does not improve survival in locoregionally advanced nasopharyngeal carcinoma.","volume":"8","author":"Fangzheng","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"zoi211085r16","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S1470-2045(18)30321-8","article-title":"Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.","volume":"19","author":"Kim","year":"2018","journal-title":"Lancet Oncol"},{"issue":"33","key":"zoi211085r17","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.1200\/JCO.2015.60.7465","article-title":"Randomized multicenter phase II study of modified docetaxel, cisplatin, and fluorouracil (DCF) versus DCF plus growth factor support in patients with metastatic gastric adenocarcinoma: a study of the US Gastric Cancer Consortium.","volume":"33","author":"Shah","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi211085r18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/(ISSN)1097-0347","article-title":"Palliative treatment with low-dose continuous infusion 5-fluorouracil in recurrent and\/or metastatic undifferentiated nasopharyngeal carcinoma type.","volume":"19","author":"Fandi","year":"1997","journal-title":"Head Neck"},{"issue":"11","key":"zoi211085r19","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1200\/JCO.2004.08.009","article-title":"Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy.","volume":"22","author":"Rich","year":"2004","journal-title":"J Clin Oncol"},{"issue":"4","key":"zoi211085r20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000226725","article-title":"5-Fluorouracil by protracted venous infusion: a review of current progress.","volume":"46","author":"Hansen","year":"1989","journal-title":"Oncology"},{"issue":"8","key":"zoi211085r21","first-page":"2203","article-title":"Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.","volume":"47","author":"Heggie","year":"1987","journal-title":"Cancer Res"},{"issue":"12","key":"zoi211085r22","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Phase I study of protracted venous infusion of 5-fluorouracil.","volume":"48","author":"Lokich","year":"1981","journal-title":"Cancer"},{"issue":"11","key":"zoi211085r23","doi-asserted-by":"publisher","first-page":"e653","DOI":"10.1016\/S1470-2045(17)30698-8","article-title":"Future cancer research priorities in the USA: a Lancet Oncology Commission.","volume":"18","author":"Jaffee","year":"2017","journal-title":"Lancet Oncol"},{"issue":"7","key":"zoi211085r25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068660","article-title":"High weight loss during radiation treatment changes the prognosis in under-\/normal weight nasopharyngeal carcinoma patients for the worse: a retrospective analysis of 2433 cases.","volume":"8","author":"Shen","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"zoi211085r26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40880-016-0139-6","article-title":"Overweight\/obese status associates with favorable outcome in patients with metastatic nasopharyngeal carcinoma: a 10-year retrospective study.","volume":"35","author":"Li","year":"2016","journal-title":"Chin J Cancer"},{"issue":"3","key":"zoi211085r27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S1470-2045(14)70064-6","article-title":"Improving the therapeutic ratio in non-operable oesophageal cancer.","volume":"15","author":"Burmeister","year":"2014","journal-title":"Lancet Oncol"},{"key":"zoi211085r28","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3389\/fonc.2020.01295","article-title":"Comparison of gemcitabine plus cisplatin vs. docetaxel plus fluorouracil plus cisplatin palliative chemotherapy for metastatic nasopharyngeal carcinoma.","volume":"10","author":"Sun","year":"2020","journal-title":"Front Oncol"},{"key":"zoi211085r29","first-page":"77","article-title":"The clinical effects of the continuous administration of fluorinated pyrimidines (5-fluorouracil and 5-fluoro-2'-deoxyuridine).","volume":"8","author":"Sullivan","year":"1960","journal-title":"Cancer Chemother Rep"},{"issue":"8","key":"zoi211085r30","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1056\/NEJM199408253310803","article-title":"Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery.","volume":"331","author":"O\u2019Connell","year":"1994","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi211085r31","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1200\/JCO.1985.3.3.402","article-title":"A pilot study of protracted venous infusion of 5-fluorouracil and concomitant radiation therapy.","volume":"3","author":"Rich","year":"1985","journal-title":"J Clin Oncol"},{"issue":"3","key":"zoi211085r32","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00520-013-2033-y","article-title":"The early discontinuation of palliative chemotherapy in older patients with cancer.","volume":"22","author":"Kim","year":"2014","journal-title":"Support Care Cancer"},{"issue":"9","key":"zoi211085r33","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1001\/jamaoncol.2020.1808","article-title":"Efficacy and safety of locoregional radiotherapy with chemotherapy vs chemotherapy alone in de novo metastatic nasopharyngeal carcinoma: a multicenter phase 3 randomized clinical trial.","volume":"6","author":"You","year":"2020","journal-title":"JAMA Oncol"},{"issue":"2","key":"zoi211085r34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group.","volume":"101","author":"Hui","year":"2004","journal-title":"Cancer"},{"issue":"36","key":"zoi211085r35","doi-asserted-by":"publisher","first-page":"eabb3116","DOI":"10.1126\/sciadv.abb3116","article-title":"A tumor-to-lymph procedure navigated versatile gel system for combinatorial therapy against tumor recurrence and metastasis.","volume":"6","author":"Qin","year":"2020","journal-title":"Sci Adv"},{"issue":"4","key":"zoi211085r36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells.","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"zoi211085r37","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1002\/ijc.27801","article-title":"Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy.","volume":"132","author":"Nars","year":"2013","journal-title":"Int J Cancer"},{"issue":"11","key":"zoi211085r38","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00262-008-0505-6","article-title":"Cancer chemotherapy: not only a direct cytotoxic effect, but also an adjuvant for antitumor immunity.","volume":"57","author":"M\u00e9nard","year":"2008","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"zoi211085r39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12307-013-0141-3","article-title":"Immunological mechanisms of low and ultra-low dose cancer chemotherapy.","volume":"8","author":"Landreneau","year":"2015","journal-title":"Cancer Microenviron"},{"issue":"8","key":"zoi211085r40","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1158\/0008-5472.CAN-09-3690","article-title":"5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity.","volume":"70","author":"Vincent","year":"2010","journal-title":"Cancer Res"},{"issue":"5","key":"zoi211085r41","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1002\/cac2.v41.5","article-title":"Diverse effects of chemotherapeutic agents on immune cell function and implications in immunochemotherapy.","volume":"41","author":"Glorieux","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"zoi211085r24","unstructured":"Efficacy and safety of platinum plus continuous intravenous infused 5-fluorouracil with low dose and long term versus other platinum-based chemotherapy in metastatic nasopharyngeal carcinoma: a case-cohort study. ClinicalTrials.gov identifier: NCT04472403. Updated July 20, 2020. Accessed October 27, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04472403?term=NCT04472403&draw=2&rank=1"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2787068\/zheng_2021_oi_211085_1638801476.55627.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T16:02:09Z","timestamp":1639411329000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2787068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,13]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.38444","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,13]]}}}